title: Marinobufagenin, an endogenous inhibitor of alpha-1 Na/K-ATPase, is a novel factor in pathogenesis of diabetes mellitus.
authors.affiliation: Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St Petersburg, Russia.
authors.forename: Y Y
authors.initials: YY
authors.lastname: Bagrov
authors.forename: N B
authors.initials: NB
authors.lastname: Manusova
authors.forename: I A
authors.initials: IA
authors.lastname: Egorova
authors.forename: E V
authors.initials: EV
authors.lastname: Frolova
authors.forename: O V
authors.initials: OV
authors.lastname: Fedorova
authors.forename: A Y
authors.initials: AY
authors.lastname: Bagrov
mesh_terms: D000818:Animals; D002018:Bufanolides / Q000378:metabolism* / Q000652:urine; D002298:Cardenolides / Q000378:metabolism; D003920:Diabetes Mellitus / Q000209:etiology* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000378:metabolism*; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D008297:Male; D010042:Ouabain / Q000378:metabolism; D020033:Protein Isoforms / Q000378:metabolism; D051381:Rats; D012503:Saponins / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*
chemical_list: D002018:Bufanolides; D002298:Cardenolides; D004791:Enzyme Inhibitors; D020033:Protein Isoforms; D012503:Saponins; C034504:digoxin-like factors; C093896:marinobufagenin; D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase